EAP
NXL icon

Elevation Advisory Partners’s Nexalin Technology NXL Stock Holding History

Elevation Advisory Partners’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$5.92K – 75
2026
Q1 		$5.92K Buy
+10,000
New +$5.21K 0.01% 97

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Elevation Advisory Partners's NXL Position: Q2 2026 in Review

Elevation Advisory Partners sold out of Nexalin Technology (NXL) in Q2 2026, closing a stake of 10,000 shares — an estimated $5.92K sold.

Elevation Advisory Partners first reported a position in NXL in Q1 2026 and held it in 1 quarter. The position peaked at $5.92K in Q1 2026. 20 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

  • Elevation Advisory Partners reported no remaining Nexalin Technology position as of Q2 2026 after selling out during the quarter.
  • Elevation Advisory Partners sold 10,000 Nexalin Technology shares in Q2 2026, an estimated $5.92K.
  • Elevation Advisory Partners first reported a position in Nexalin Technology in Q1 2026 and held it in 1 quarter.
  • Elevation Advisory Partners's Nexalin Technology position peaked at $5.92K in Q1 2026.
  • 20 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Elevation Advisory Partners's 13F filing for Q2 2026, filed 13 Aug 2026.